Cargando…

The timing and design of stereotactic radiotherapy approaches as a part of neoadjuvant therapy in pancreatic cancer: Is it time for change?

Stereotactic Radiotherapy (SRT) over 5-15 days can be interdigitated without delaying chemotherapy. Bridging chemotherapy may allow for extended intervals to surgery, potentially improving sterilization of surgical margins and overall survival. SRT for pancreatic adenocarcinoma should not be limited...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ryckman, Jeffrey M., Reames, Bradley N., Klute, Kelsey A., Hall, William A., Baine, Michael J., Abdel-Wahab, May, Lin, Chi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8085778/ https://www.ncbi.nlm.nih.gov/pubmed/33981865 http://dx.doi.org/10.1016/j.ctro.2021.04.002

Ejemplares similares

Correlation of dosimetric factors with the development of symptomatic radiation pneumonitis in stereotactic body radiotherapy
por: Ryckman, Jeffrey M., et al.
Publicado: (2020)

Correction to: Correlation of dosimetric factors with the development of symptomatic radiation pneumonitis in stereotactic body radiotherapy
por: Ryckman, Jeffrey M., et al.
Publicado: (2021)

Radiomics-Based Outcome Prediction for Pancreatic Cancer Following Stereotactic Body Radiotherapy
por: Parr, Elsa, et al.
Publicado: (2020)

Stereotactic body radiation therapy mitigates radiation induced lymphopenia in early stage non-small cell lung cancer
por: McLaughlin, Mark F., et al.
Publicado: (2020)

Pathologic response with neoadjuvant chemotherapy and stereotactic body radiotherapy for borderline resectable and locally-advanced pancreatic cancer
por: Rajagopalan, Malolan S, et al.
Publicado: (2013)

Quantifying Reoxygenation in Pancreatic Cancer During Stereotactic Body Radiotherapy
por: Taylor, Edward, et al.
Publicado: (2020)

The impact of neoadjuvant and adjuvant immunotherapy on the survival of pancreatic cancer patients: a retrospective analysis
por: Amin, Saber, et al.
Publicado: (2020)

Stereotactic Radiotherapy and Particle Therapy for Pancreatic Cancer
por: Ng, Sweet Ping, et al.
Publicado: (2018)

Neuroendocrine Carcinoma of Uterine Cervix: Stereotactic Radiotherapy for Brain Metastasis and Stereotactic Body Radiotherapy for Renal and Pancreatic Metastases
por: Mori, Yoshimasa, et al.
Publicado: (2020)

Stereotactic Body Radiotherapy as an Effective Treatment for Pancreatic Cancer
por: Hurmuz, Pervin, et al.
Publicado: (2023)

Stereotactic body radiotherapy in the treatment of Pancreatic Adenocarcinoma in elderly patients
por: Kim, Carolyn H, et al.
Publicado: (2013)

Neoadjuvant Treatment in Resectable Pancreatic Cancer. Is It Time for Pushing on It?
por: Vivarelli, Marco, et al.
Publicado: (2022)

Isotoxic high-dose stereotactic body radiotherapy integrated in a total multimodal neoadjuvant strategy for the treatment of localized pancreatic ductal adenocarcinoma
por: Bouchart, Christelle, et al.
Publicado: (2021)

Adaptive hypofractionted and stereotactic body radiotherapy for lung tumors with real-time MRI guidance
por: Bryant, John M., et al.
Publicado: (2023)

Effects of two different radiotherapies for craniopharyngiomas using stereotactic radiosurgery/ stereotactic radiotherapy or fractionated stereotactic radiotherapy
por: Kamogawa, Misaki, et al.
Publicado: (2022)

Real-Time Tumor-Tracking Radiotherapy and General Stereotactic Body Radiotherapy for Adrenal Metastasis in Patients With Oligometastasis
por: Katoh, Norio, et al.
Publicado: (2018)

Application of stereotactic body radiotherapy in advanced pancreatic cancers in Australia
por: Kim, Laurence, et al.
Publicado: (2018)

Stereotactic Radiotherapy for Pancreatic Cancer: A Single-Institution Experience
por: Glicksman, Rachel M, et al.
Publicado: (2020)

Lymphocyte-sparing effect of stereotactic body radiation therapy compared to conventional fractionated radiation therapy in patients with locally advanced pancreatic cancer
por: Wu, Guangyin, et al.
Publicado: (2019)

MET-6 Neoadjuvant fractionated stereotactic radiotherapy followed by piecemeal resection for metastatic brain tumor
por: Mitsuya, Koichi, et al.
Publicado: (2021)

Neoadjuvant Stereotactic Radiotherapy for Brain Metastases: Systematic Review and Meta-Analysis of the Literature and Ongoing Clinical Trials
por: Palmisciano, Paolo, et al.
Publicado: (2022)

Impact of somatic mutations on clinical and pathologic outcomes in borderline resectable and locally advanced pancreatic cancer treated with neoadjuvant chemotherapy and stereotactic body radiotherapy followed by surgical resection
por: Reddy, Abhinav V., et al.
Publicado: (2021)

Volumetric Regression in Brain Metastases After Stereotactic Radiotherapy: Time Course, Predictors, and Significance
por: Oft, Dominik, et al.
Publicado: (2021)

Selection of motion management in liver stereotactic body radiotherapy and its impact on treatment time
por: Hardcastle, Nicholas, et al.
Publicado: (2023)

Stereotactic radiosurgery and stereotactic radiotherapy for brain metastases
por: Halasz, Lia M., et al.
Publicado: (2013)

Stereotactic radiotherapy of pancreatic cancer: a systematic review on pain relief
por: Buwenge, Milly, et al.
Publicado: (2018)

Effect of stomach size on organs at risk in pancreatic stereotactic body radiotherapy
por: Tanaka, Osamu, et al.
Publicado: (2022)

Re-Irradiation With Stereotactic Body Radiotherapy for In-Field Recurrence of Pancreatic Cancer After Prior Stereotactic Body Radiotherapy: Analysis of 24 Consecutive Cases
por: Shen, Yuxin, et al.
Publicado: (2021)

Stereotactic Radiotherapy for Oligometastasis
por: Otake, Sotaro, et al.
Publicado: (2019)

Radiobiology of stereotactic radiotherapy
por: Mangoni, Monica, et al.
Publicado: (2022)

Real‐time intrafraction prostate motion during linac based stereotactic radiotherapy with rectal displacement
por: Legge, Kimberley, et al.
Publicado: (2017)

Real‐time high spatial resolution dose verification in stereotactic motion adaptive arc radiotherapy
por: Duncan, Mitchell, et al.
Publicado: (2018)

Real-time measurement of ICD lead motion during stereotactic body radiotherapy of ventricular tachycardia
por: Knybel, Lukas, et al.
Publicado: (2021)

The timing of surgery after neoadjuvant radiotherapy influences tumor dissemination in a preclinical model
por: Leroi, Natacha, et al.
Publicado: (2015)

Dosimetric and motion analysis of margin-intensive therapy by stereotactic ablative radiotherapy for resectable pancreatic cancer
por: Heinzerling, John H, et al.
Publicado: (2011)

Pain Relief after Stereotactic Radiotherapy of Pancreatic Adenocarcinoma: An Updated Systematic Review
por: Buwenge, Milly, et al.
Publicado: (2022)

The treatment of a large acoustic tumor with fractionated stereotactic radiotherapy
por: McClelland, Shearwood, et al.
Publicado: (2007)

Neoadjuvant fractionated stereotactic radiotherapy followed by piecemeal resection of brain metastasis: a case series of 20 patients
por: Deguchi, Shoichi, et al.
Publicado: (2021)

RONC-06. Stereotactic radiosurgery and stereotactic radiotherapy for pediatric brain metastases or recurrences
por: McGovern, Susan, et al.
Publicado: (2022)

The impact of digital stereotactic devices on examination times
por: Burch, A, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_cjqphpsg088nbk5vub8n5v75br